CN103191390A - Medicine for treating climacteric syndrome - Google Patents
Medicine for treating climacteric syndrome Download PDFInfo
- Publication number
- CN103191390A CN103191390A CN 201310111441 CN201310111441A CN103191390A CN 103191390 A CN103191390 A CN 103191390A CN 201310111441 CN201310111441 CN 201310111441 CN 201310111441 A CN201310111441 A CN 201310111441A CN 103191390 A CN103191390 A CN 103191390A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- fructus
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 18
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 16
- 229940079593 drug Drugs 0.000 title 1
- 241000903946 Clematidis Species 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 244000268590 Euryale ferox Species 0.000 claims abstract description 4
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 4
- 241000132446 Inula Species 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 10
- 241001164374 Calyx Species 0.000 claims description 5
- 244000064622 Physalis edulis Species 0.000 claims description 5
- 239000009609 fructus phyllanthi Substances 0.000 claims description 3
- 241000726094 Aristolochia Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 241001180876 Saposhnikovia Species 0.000 claims description 2
- 241000736026 Sarcandra Species 0.000 claims description 2
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 2
- 241001530126 Scrophularia Species 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 240000001972 Gardenia jasminoides Species 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241001233914 Chelidonium majus Species 0.000 abstract 1
- 241001563035 Clinopodium polycephalum Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000119298 Emblica officinalis Species 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 235000014266 Geum aleppicum Nutrition 0.000 abstract 1
- 241000123870 Geum aleppicum Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 235000010254 Jasminum officinale Nutrition 0.000 abstract 1
- 240000005385 Jasminum sambac Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241001465382 Physalis alkekengi Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241001571466 Potentilla discolor Species 0.000 abstract 1
- 241000681946 Rhododendron dauricum Species 0.000 abstract 1
- 240000008199 Rhododendron molle Species 0.000 abstract 1
- 240000004274 Sarcandra glabra Species 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000007357 hyperpituitarism Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001294 luteotrophic effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating climacteric syndrome. The medicine is prepared from the following substances in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of seed of cowherb, 1-15 parts of herba aristolochiae, 10-20 parts of radices sileris, 15-30 parts of oriental wormwood, 20-30 parts of mangnolia officinalis, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of radix clematidis, 10-30 parts of jasmine, 10-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of kaladana, 15-20 parts of herba Inulae, 15-30 glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of chinese lantern-plant, 15-25 parts of root bark of white mulberry, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of chinese azalea flower. All ingredients of the medicine for treating the climacteric syndrome are natural materials, and are good in security, accurate in curative effect and suitable for clinical large-scale popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of climacteric syndrome.
Background technology
Climacteric syndrome is a series of symptoms that caused by decrease in estrogen.Climacteric women, because hypo-ovaria, hyperpituitarism, the promoting sexual gland hormone of supersecretion causes the autonomic nervous dysfunction, thereby the different symptom of a series of degree occurs, as menstruation variation, flushed face, cardiopalmus, insomnia, weak, depressed, worry too much, emotional instability, emotional, attention is difficult to concentrate etc., is called " climacteric syndrome ".
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of climacteric syndrome.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of climacteric syndrome, it is to be made by following materials by weight: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Artemisiae Scopariae 15-30 part, Cortex Magnoliae Officinalis 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Radix Clematidis 10-25 part, Fructus Gardeniae 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
Preferably, the medicament for the treatment of climacteric syndrome of the present invention is to be made by following materials by weight: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts of Herba Artemisiae Scopariaes, 27 parts of Cortex Magnoliae Officinalis, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Radix Clematidis, 21 parts of Fructus Gardeniaes, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of climacteric syndrome of the present invention all are natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further specify the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
Embodiment decoction of the present invention
Take by weighing Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Artemisiae Scopariae 24 grams, Cortex Magnoliae Officinalis 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Radix Clematidis 23 grams, Fructus Gardeniae 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Semen Euryales 16 grams and Flos Rhododendri Mollis 24 grams, add water 2000 milliliters, in the flask of condensing tube is housed, heated 4 hours down at 80 ℃, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.
Experimental example
One, patient's data
Case is selected in diagnostic criteria with reference to the clinical research guideline of female climacteric syndrome " the Ministry of Public Health new Chinese medicine treatment ", and clinical manifestation all has in various degree menoxenia, warms sweating, irritated irritability, palpitation and insomnia, head uncomfortable in chest add, abnormal emotion-thought, hypomnesis, the acid of waist lower limb add etc.Get rid of aspect disease such as heart and brain blood bamboo, spirit nerve, liver, kidney, hemopoietic system and bilateral ovaries excision, ovarian tumor and premature ovarian failure, hyperthyroidism person through general physical checkup.Serum estrogen (E
2) level all has decline in various degree, follicule-stimulating hormone (FSH) (FSH) and luteotropic hormone (LH) level raise.Choose the 30 routine patients that meet above-mentioned requirements, 42 years old-55 years old age.
Two, Therapeutic Method
Use the decoction for preparing among the embodiment to treat, every day 2 times, each oral 50 milliliters.Treating 1 month is 1 course for the treatment of.
Three, efficacy assessment standard
Formulate criterion of therapeutical effect with reference to Ministry of Public Health " the clinical research guideline of new Chinese medicine treatment female climacteric syndrome ".Cure: clinical symptom disappearance, the physico-chemical examination result recovers respective horizontal.Take a turn for the better: clinical symptoms takes a turn for the better to some extent, and physico-chemical examination is the result make moderate progress.Invalid: symptom, sign, physical and chemical index all do not have improvement or worsen.
Four, result
Whole 30 routine patients all meet the standard of healing after the treatment through a course for the treatment of.And, in therapeutic process, do not find tangible untoward reaction.
Claims (3)
1. medicament for the treatment of climacteric syndrome, it is characterized in that it is to be made by following materials by weight: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Artemisiae Scopariae 15-30 part, Cortex Magnoliae Officinalis 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Radix Clematidis 10-25 part, Fructus Gardeniae 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of climacteric syndrome according to claim 1, it is characterized in that it is to be made by following materials by weight: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts of Herba Artemisiae Scopariaes, 27 parts of Cortex Magnoliae Officinalis, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Radix Clematidis, 21 parts of Fructus Gardeniaes, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
3. the medicament for the treatment of climacteric syndrome according to claim 1 is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310111441 CN103191390A (en) | 2013-03-22 | 2013-03-22 | Medicine for treating climacteric syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310111441 CN103191390A (en) | 2013-03-22 | 2013-03-22 | Medicine for treating climacteric syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103191390A true CN103191390A (en) | 2013-07-10 |
Family
ID=48714323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201310111441 Pending CN103191390A (en) | 2013-03-22 | 2013-03-22 | Medicine for treating climacteric syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103191390A (en) |
-
2013
- 2013-03-22 CN CN 201310111441 patent/CN103191390A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102166278B (en) | Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof | |
| CN103157087A (en) | Drug for treating femoral head necrosis | |
| CN101897868B (en) | Chinese medicinal composition for treating psoriasis and preparation method thereof | |
| CN101972446B (en) | Medicament for treating coronary disease and preparation method thereof | |
| CN102145057A (en) | Antispasmodic traditional Chinese medicine composition and preparation method thereof | |
| CN101306138B (en) | Chinese traditional injection preparation for treating chest stuffiness and pains and its preparation method | |
| CN102000256A (en) | Traditional Chinese medicine composition for treating hypoglycemia | |
| CN101961386A (en) | Traditional Chinese medicine for treating diabetic skin pruritus | |
| CN102526385B (en) | Medicament for treating climacteric syndrome | |
| CN103142981A (en) | Medicament for treating mammitis | |
| CN102836338A (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
| CN103142974B (en) | Medicament for treating anxiety disorder | |
| CN102114077A (en) | Traditional Chinese medicine for treating diabetic skin pruritus | |
| CN101953892A (en) | Traditional Chinese medicine for treating diabetic cutaneous pruritus | |
| CN101708300A (en) | Medicinal composition for treating scrofula, hyperplasia of mammary glands and benign lymphadenoma | |
| CN103191390A (en) | Medicine for treating climacteric syndrome | |
| CN103157091A (en) | Drug for treating empyrosis | |
| CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
| CN103007236B (en) | Chinese medicinal composition for treating ankylosing spondylitis | |
| CN1318066C (en) | Medicine for treating dysmenorrhes and preparation thereof | |
| CN102614375B (en) | Traditional Chinese medicine compound for tonifying kidney, strengthening yang and treating impotence and preparing method thereof | |
| CN103142960B (en) | Medicament for treating skin diseases | |
| CN105267939A (en) | Traditional Chinese medicine composition for treating superficial phlebitis | |
| CN103028062B (en) | Traditional Chinese medicine for treating ankylosing spondylitis | |
| CN103142977A (en) | Medicament for treating dysmenorrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130710 |